Introduction The carotid body (CB) has previously been found to be enlarged and hyperactive in various disease states such as heart failure (HF), hypertension (HTN), and respiratory disease. Evaluation of CB size in these disease states using imaging has not been performed. The purpose of this case-control study was to compare CB sizes in patients with HF and HTN with those of controls using CT angiography. Methods A retrospective review was performed on 323 consecutive patients who had neck computed tomography angiography (CTA) exams in 2011. Following extensive review, 17 HF and HTN patients and 14 controls were identified. Two radiologists blinded to the patient disease status made consensus bilateral carotid body (CB) measurements on the CTA exams using a previously described standardized protocol. CB axial cross-sectional areas were compared between HF and HTN cases and controls using a paired t test.
Introduction
The carotid bodies are the primary sensors of hypoxemia and the main sensors of carbon dioxide and pH outside of the brain. They have been found to be hyperactive in various disease states. Historical literature from the 1970s provided evidence that the carotid bodies are enlarged in respiratory disease states (asthma, chronic obstructive pulmonary disease (COPD), and emphysema) [1, 2] . Several human cadaver studies indicated a significant correlation between the combined weights of the carotid bodies and the weight of both the right and left ventricles [1, 2] . This finding suggests that the carotid bodies could play a role in the development or progression of cardiovascular diseases like heart failure (HF). Subsequent studies have found carotid body (CB) enlargement in animals with genetic hypertension (HTN; spontaneous hypertensive rats) [3] [4] [5] . Modern literature provides increasing evidence that the carotid bodies play a major role in modulating sympathetic activation in disease states like HF and HTN [6] [7] [8] [9] [10] .
A recent study investigating the role of neck computed tomography angiography (CTA) in detecting the CB found that the CB can be reliably detected on CTA [11] . To our knowledge, there has not been any prior imaging study correlating CB size to specific disease states. The purpose of this case-control study was to compare CB sizes in patients with both HF and HTN with those of controls without HF, HTN, or any other potentially confounding conditions (cirrhosis, respiratory disease, lactic acidosis, or hemoglobinopathy) using CTA.
Methods
The study was approved by the institutional review board. Retrospective review was performed on 323 consecutive patients who had neck CTA exams in 2011. Patients with HF and HTN were identified based on a diagnosis in the medical record within 6 months of the CTA exam. Confounding exclusionary conditions were placed in three main categories: (1) hepatic disorders, such as cirrhosis, (2) pulmonary disorders, such as COPD or chronic interstitial lung disease, and (3) hematologic or metabolic abnormalities, such as lactic acidosis or hemoglobinopathy. Patients with insufficient chart information to confirm the presence or absence of these conditions were excluded from the study. From the 323 neck CTAs screened, 17 adult patients with HF and HTN were identified.
Fourteen patients had conclusive information excluding the presence of the above confounding conditions and were identified as controls (Fig. 1) .
Two board-certified radiologists blinded to the patients' case or control status made consensus bilateral CB measurements on the CTA exams. Our departmental CTA protocol uses bolus tracking via premonitoring scans at the level of the aortic arch, with an ROI placed within the ascending aorta. Helical 0.625-mm collimated images were acquired from the inferior aspect of the aortic arch to the superior aspect of the frontal sinus, with a pitch of 1.0 at 120 kV. One hundred milliliters of contrast was injected through an 18-gauge antecubital fossa intravenous line at a rate of 4 ml/s. The matrix size of the scanner was 512×512. Measurement tools allowed measurement of differences of 0.1 mm. Measurements were made using a standardized protocol with PACS (picture archiving and communication system) measurement tools at 200 % magnification to determine longitudinal and transverse axial dimensions [11] . The CB was identified on each side by searching for an avidly enhancing structure in the characteristic location of the CB at the inferomedial aspect of the carotid bifurcation. Given the consistent oval or elliptical configuration of the CB on axial images, the difficulties in obtaining an accurate craniocaudal measurement, and the spatial limitations of multiplanar coronal reformatted images, Tables 2 and 3) . No difference between the right and left CBs was detected in either group. While the right-and left-sided CBs in the HF and HTN groups showed a strong positive correlation, the CBs in the control group showed no or only negligible positive correlation (Tables 4 and 5 ).
Discussion
The CB may contribute to increased sympathetic activation in cardiovascular diseases like HF and HTN [10] . Prior pathologic studies have uncovered a positive correlation between the increased size of the CB and the presence of these disease states [1, 12] . Proposed mechanisms for hyperactivity and enlargement of these chemoreceptors include decreased perfusion, changes in acid-sensing ion channels, and shifts in the relative activities of hypoxia-inducible factors (HIF1 and HIF2) [12] [13] [14] [15] . Analysis of the CB in an animal model of genetic HTN showed the glomus cells to be hypertrophied, suggesting an increase in protein synthesis and angiogenesis [16] .
The CB is a highly perfused organ [17] , making it visible on CTA. In 2011, Nguyen et al. confirmed the ability to consistently detect the carotid body in a series of patients who underwent CTA for various indications [11] . In our retrospective blinded case-control study of 17 patients with HF and HTN and 14 controls, we tested the hypothesis that CTA can be used to show enlargement of the CB in HF and HTN. We found that the CB cross-sectional areas measured on CTA are significantly increased in HF and HTN compared to controls. Similar to Nguyen et al., we have shown a positive correlation between the size of the right and left CBs. However, we show this correlation only with HF and HTN patients and not with the control population, possibly due to our relatively smaller sample size.
The pathophysiologic significance of the CB in HF and HTN has been recognized in both historical and more recent literature [10, 18] . Interestingly, overactivity of the CB has been linked to a higher mortality rate in patients with HF [10, 19] . Importantly, it is still unclear whether this overactivity is a cause or effect of its anatomical size. The temporal relationship between CB size changes and the onset of HTN and CHF is also unclear. However, as seen in this study, CTA may be a non-invasive tool to visualize the CB. With further validation and confirmation, the ability to reliably detect "pathological" Fig. 3 CTA axial image in a 51-year-old male with heart failure and hypertension demonstrates enlarged right carotid body (arrowhead) at the bifurcation of the right internal (black arrow) and external (white arrow) carotid arteries CB enlargement with CTA may make it the imaging modality of choice for monitoring treatments aimed at modulating CB activity. Since radiation exposure is a potential hazard of CTA, the utility of MRI/MRA in this setting should also be investigated.
Given the retrospective nature of this study and the limitations of chart review, there may have been some degree of inaccuracy selecting cases and controls. However, to limit this potential bias, we were strict in including only cases and controls with adequate chart documentation of inclusion and exclusion criteria. Altitude also may affect CB size and function, but the retrospective nature of the study did not allow us to collect this specific information. Most patients, however, were drawn from the New York City metropolitan area and were therefore near sea level. A second limitation was our relatively low N. The small sample size limited our ability to perform additional and potentially informative analyses such as correlating ejection fraction/blood pressure with CB size and distinguishing between the effects of HF and HTN on CB size. This small sample size may also account for the greater variation in CB size compared with that of Nguyen et al. However, the significant difference between the CB crosssectional areas of HF and HTN cases and controls demonstrates that our study was sufficiently powered to provide meaningful preliminary data regarding our primary outcome measure. A high percentage of the left CBs were not visualized in our analysis; it is possible that such an observation may be due to suppression by the contralateral hypertrophied CB. Further studies will hopefully clarify the influence of one carotid body on the other. Validation of these results will require additional prospective studies with larger patient populations.
Conclusion
Our case-control series provides CTA evidence that the carotid bodies are enlarged in HF and HTN. CTA could potentially guide and monitor future therapies directed at carotid body overactivity. Further validation of these results with a larger prospective study is required. 
